Denali Therapeutics Inc. announced that it will host a live webcast to review presentations on its Enzyme TransportVehicle™ $(ETV)$ programs at the 22nd Annual WORLDSymposium™ in San Diego, California. The event will highlight the potential of the ETV platform to deliver enzyme replacement therapies to the whole body, including the brain. The webcast is scheduled for 12:30 p.m. Pacific Time on February 5, 2026, and will be accessible through the Investor section of Denali's corporate website.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Denali Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9646852-en) on February 02, 2026, and is solely responsible for the information contained therein.
Comments